Skip to main content
See every side of every news story
Published loading...Updated

Insider Selling: Mineralys Therapeutics (NASDAQ:MLYS) CFO Sells $5,364,237.12 in Stock

Summary by defenseworld.net
Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Get Free Report) CFO Adam Scott Levy sold 119,524 shares of the company’s stock in a transaction dated Tuesday, November 11th. The stock was sold at an average price of $44.88, for a total value of $5,364,237.12. Following the sale, the chief financial officer owned 19,396 shares in the company, valued at $870,492.48. The trade was a 86.04% decrease in their position. The transaction was disclosed in a…

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

defenseworld.net broke the news in on Sunday, November 16, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal